vs
QuidelOrtho Corp（QDEL）与VIASAT INC（VSAT）财务数据对比。点击上方公司名可切换其他公司
VIASAT INC的季度营收约是QuidelOrtho Corp的1.7倍（$1.2B vs $699.9M），VIASAT INC净利率更高（2.2% vs -104.7%，领先106.9%），VIASAT INC同比增速更快（3.0% vs -3.7%），过去两年VIASAT INC的营收复合增速更高（0.3% vs -2.9%）
奎德尔奥索公司是美国的诊断医疗产品制造商，旗下产品面向全球市场销售，深耕体外诊断领域，为医疗机构及相关用户提供专业的检测解决方案，助力全球医疗健康服务效率提升。
Viasat Inc.是总部坐落于美国加利福尼亚州卡尔斯巴德的通信企业，业务覆盖美国全境及全球多个国家和地区，面向军用与商业市场提供高速卫星宽带服务及安全网络系统相关解决方案。
QDEL vs VSAT — 直观对比
营收规模更大
VSAT
是对方的1.7倍
$699.9M
营收增速更快
VSAT
高出6.7%
-3.7%
净利率更高
VSAT
高出106.9%
-104.7%
两年增速更快
VSAT
近两年复合增速
-2.9%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $699.9M | $1.2B |
| 净利润 | $-733.0M | $25.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.7% | 2.3% |
| 净利率 | -104.7% | 2.2% |
| 营收同比 | -3.7% | 3.0% |
| 净利润同比 | -3583.4% | 115.8% |
| 每股收益（稀释后） | $-10.78 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QDELVSAT
| Q4 25 | — | $1.2B | ||
| Q3 25 | $699.9M | $1.1B | ||
| Q2 25 | $613.9M | $1.2B | ||
| Q1 25 | $692.8M | $1.1B | ||
| Q4 24 | $707.8M | $1.1B | ||
| Q3 24 | $727.1M | $1.1B | ||
| Q2 24 | $637.0M | $1.1B | ||
| Q1 24 | $711.0M | $1.2B |
净利润QDELVSAT
| Q4 25 | — | $25.0M | ||
| Q3 25 | $-733.0M | $-61.4M | ||
| Q2 25 | $-255.4M | $-56.4M | ||
| Q1 25 | $-12.7M | $-246.1M | ||
| Q4 24 | $-178.4M | $-158.4M | ||
| Q3 24 | $-19.9M | $-137.6M | ||
| Q2 24 | $-147.7M | $-32.9M | ||
| Q1 24 | $-1.7B | $-100.3M |
营业利润率QDELVSAT
| Q4 25 | — | 2.3% | ||
| Q3 25 | -100.7% | 3.1% | ||
| Q2 25 | -29.4% | 4.0% | ||
| Q1 25 | 4.7% | -13.4% | ||
| Q4 24 | -14.2% | 1.9% | ||
| Q3 24 | 2.1% | -2.2% | ||
| Q2 24 | -18.4% | 5.3% | ||
| Q1 24 | -247.3% | 0.0% |
净利率QDELVSAT
| Q4 25 | — | 2.2% | ||
| Q3 25 | -104.7% | -5.4% | ||
| Q2 25 | -41.6% | -4.8% | ||
| Q1 25 | -1.8% | -21.5% | ||
| Q4 24 | -25.2% | -14.1% | ||
| Q3 24 | -2.7% | -12.3% | ||
| Q2 24 | -23.2% | -2.9% | ||
| Q1 24 | -239.9% | -8.7% |
每股收益（稀释后）QDELVSAT
| Q4 25 | — | $0.18 | ||
| Q3 25 | $-10.78 | $-0.45 | ||
| Q2 25 | $-3.77 | $-0.43 | ||
| Q1 25 | $-0.19 | $-1.92 | ||
| Q4 24 | $-2.54 | $-1.23 | ||
| Q3 24 | $-0.30 | $-1.07 | ||
| Q2 24 | $-2.20 | $-0.26 | ||
| Q1 24 | $-25.50 | $-1.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.1M | $1.3B |
| 总债务越低越好 | $2.5B | $6.2B |
| 股东权益账面价值 | $2.0B | $4.6B |
| 总资产 | $5.7B | $14.9B |
| 负债/权益比越低杠杆越低 | 1.23× | 1.37× |
8季度趋势，按日历期对齐
现金及短期投资QDELVSAT
| Q4 25 | — | $1.3B | ||
| Q3 25 | $98.1M | $1.2B | ||
| Q2 25 | $151.7M | $1.2B | ||
| Q1 25 | $127.1M | $1.6B | ||
| Q4 24 | $98.3M | $1.6B | ||
| Q3 24 | $143.7M | $3.5B | ||
| Q2 24 | $107.0M | $1.8B | ||
| Q1 24 | $78.5M | $1.9B |
总债务QDELVSAT
| Q4 25 | — | $6.2B | ||
| Q3 25 | $2.5B | $6.5B | ||
| Q2 25 | $2.1B | $6.5B | ||
| Q1 25 | $2.1B | $6.5B | ||
| Q4 24 | $2.1B | $6.5B | ||
| Q3 24 | $2.2B | $6.4B | ||
| Q2 24 | $2.2B | $7.1B | ||
| Q1 24 | $2.2B | $7.1B |
股东权益QDELVSAT
| Q4 25 | — | $4.6B | ||
| Q3 25 | $2.0B | $4.5B | ||
| Q2 25 | $2.8B | $4.6B | ||
| Q1 25 | $3.0B | $4.6B | ||
| Q4 24 | $3.0B | $4.8B | ||
| Q3 24 | $3.2B | $4.9B | ||
| Q2 24 | $3.2B | $5.0B | ||
| Q1 24 | $3.3B | $5.0B |
总资产QDELVSAT
| Q4 25 | — | $14.9B | ||
| Q3 25 | $5.7B | $14.8B | ||
| Q2 25 | $6.4B | $14.9B | ||
| Q1 25 | $6.5B | $15.4B | ||
| Q4 24 | $6.4B | $15.6B | ||
| Q3 24 | $6.8B | $17.8B | ||
| Q2 24 | $6.7B | $16.1B | ||
| Q1 24 | $6.7B | $16.3B |
负债/权益比QDELVSAT
| Q4 25 | — | 1.37× | ||
| Q3 25 | 1.23× | 1.44× | ||
| Q2 25 | 0.74× | 1.43× | ||
| Q1 25 | 0.70× | 1.43× | ||
| Q4 24 | 0.72× | 1.37× | ||
| Q3 24 | 0.68× | 1.30× | ||
| Q2 24 | 0.70× | 1.42× | ||
| Q1 24 | 0.68× | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.5M | $726.9M |
| 自由现金流经营现金流 - 资本支出 | $-94.7M | — |
| 自由现金流率自由现金流/营收 | -13.5% | — |
| 资本支出强度资本支出/营收 | 7.0% | — |
| 现金转化率经营现金流/净利润 | — | 29.11× |
| 过去12个月自由现金流最近4个季度 | $-153.1M | — |
8季度趋势，按日历期对齐
经营现金流QDELVSAT
| Q4 25 | — | $726.9M | ||
| Q3 25 | $-45.5M | $282.2M | ||
| Q2 25 | $-46.8M | $258.5M | ||
| Q1 25 | $65.6M | $298.4M | ||
| Q4 24 | $63.7M | $219.5M | ||
| Q3 24 | $117.9M | $239.2M | ||
| Q2 24 | $-97.9M | $151.1M | ||
| Q1 24 | $-700.0K | $232.0M |
自由现金流QDELVSAT
| Q4 25 | — | — | ||
| Q3 25 | $-94.7M | — | ||
| Q2 25 | $-84.3M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $16.5M | — | ||
| Q3 24 | $71.4M | — | ||
| Q2 24 | $-133.2M | — | ||
| Q1 24 | $-66.8M | — |
自由现金流率QDELVSAT
| Q4 25 | — | — | ||
| Q3 25 | -13.5% | — | ||
| Q2 25 | -13.7% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 9.8% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -9.4% | — |
资本支出强度QDELVSAT
| Q4 25 | — | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 9.3% | — |
现金转化率QDELVSAT
| Q4 25 | — | 29.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
VSAT
| Products | $334.2M | 29% |
| Aviation Services | $303.7M | 26% |
| Government Satcom Services | $202.4M | 17% |
| Maritime Services | $114.9M | 10% |
| Information Security And Cyber Defense Products | $97.0M | 8% |
| Tactical Networking Products | $93.9M | 8% |
| Navarino Uk And Jsat Mobile | $15.5M | 1% |
| Advanced Technologies And Other Products | $6.1M | 1% |
